menu
    • menu

    Company profile for Laurent Pharmaceuticals

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Laurent Pharmaceuticals is a Montréal-based private biopharmaceutical company. Laurent has a clinical stage lead program focusing on LAU-7b, a once-a-day oral therapy addressing the persistent unresolved inflammation, a leading cause of lung tissue destruction in patients with Cystic Fibrosis (CF).The underlying technology was developed at the Research Institute of the McGill University Health Centre (RI-MUHC) and received an...
    Laurent Pharmaceuticals is a Montréal-based private biopharmaceutical company. Laurent has a clinical stage lead program focusing on LAU-7b, a once-a-day oral therapy addressing the persistent unresolved inflammation, a leading cause of lung tissue destruction in patients with Cystic Fibrosis (CF).The underlying technology was developed at the Research Institute of the McGill University Health Centre (RI-MUHC) and received an Orphan Drug Designation from the U.S. Food and Drug Administration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Laurent PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    355 Peel, Suite 503 Montréal (Québec) H3C 2G9
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://laurentpharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/laurent-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof

    Cosmoprof

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Laurent Receives Health Canada’s Approval to Initiate Ph 2/3 Trial in Long COVID
    Laurent Receives Health Canada’s Approval to Initiate Ph 2/3 Trial in Long COVID

    29 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230829616631/en

    BUSINESSWIRE
    29 Aug 2023
    Share Share
    Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b
    Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b

    03 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221103005075/en

    BUSINESSWIRE
    03 Nov 2022
    Share Share
    Laurent Pharma Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Drug
    Laurent Pharma Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Drug

    15 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220215005504/en

    BUSINESSWIRE
    15 Feb 2022
    Share Share
    Laurent Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b
    Laurent Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b

    15 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211215005240/en

    BUSINESSWIRE
    15 Dec 2021
    Share Share
    Laurent’s LAU-7b fails to meet primary goal in Phase II Covid-19 trial
    Laurent’s LAU-7b fails to meet primary goal in Phase II Covid-19 trial

    04 Oct 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/laurent-lau-7b-covid-trial/

    CLINICALTRIALSARENA
    04 Oct 2021
    Share Share
    Laurent Announces Topline Results from its Phase 2 RESOLUTION Trial of LAU-7b
    Laurent Announces Topline Results from its Phase 2 RESOLUTION Trial of LAU-7b

    30 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210930005182/en

    BUSINESSWIRE
    30 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search